Hollestelle, A; Van Der Baan, FH; Berchuck, A; Johnatty, SE; Aben, KK; Agnarsson, BA; et al.(2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141(2), 386-401. doi: 10.1016/j.ygyno.2015.04.034. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2w30z17d